“Application of Nanocarrier-Based Targeted Drug Delivery in the Treatment of Liver Fibrosis and Vascular Diseases”. 2025. Journal of Medicine and Life Sciences 1 (2): 63-69. https://doi.org/10.71222/bc9c9s73.